Venture capital investments by Abbott are managed through two subsidiaries that work closely together: Abbott Ventures, Inc. (AVI), which is focused on medical devices and diagnostics, and Abbott Biotech Ventures, Inc. (ABVI), which is focused on biotech and pharmaceuticals.

Both AVI and ABVI are devoted to investing in companies doing innovative work with the potential to significantly improve health and the practice of health care. The goal of each organization is to identify and fund promising early- to mid-stage opportunities that build on Abbott’s 120+ year legacy of advancing science to help people live healthier lives.

To enhance Abbott’s long-term growth through structured equity investments that result in access to innovative, early-stage medical technology and biopharmaceutical assets with significant market potential.